|
ZNF641 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.42810224651657E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.24970000301172E-08 |
| Normal-vs-Stage2 |
1.785700E-04 |
| Normal-vs-Stage3 |
9.83657599817889E-13 |
| Normal-vs-Stage4 |
5.70500313656908E-11 |
| Stage1-vs-Stage2 |
5.051200E-01 |
| Stage1-vs-Stage3 |
1.351890E-02 |
| Stage1-vs-Stage4 |
7.122700E-03 |
| Stage2-vs-Stage3 |
1.672480E-02 |
| Stage2-vs-Stage4 |
1.284330E-02 |
| Stage3-vs-Stage4 |
6.076400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.59360002760911E-10 |
| Normal-vs-AfricanAmerican |
1.98429999999084E-05 |
| Normal-vs-Asian |
5.42740000053499E-07 |
| Caucasian-vs-AfricanAmerican |
7.758600E-01 |
| Caucasian-vs-Asian |
9.918200E-01 |
| AfricanAmerican-vs-Asian |
8.174200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.39435163204871E-12 |
| Normal-vs-Female |
1.69829994511872E-09 |
| Male-vs-Female |
1.075010E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.99080000157426E-08 |
| Normal-vs-Age(41-60Yrs) |
3.05720004867283E-09 |
| Normal-vs-Age(61-80Yrs) |
3.46930040251436E-10 |
| Normal-vs-Age(81-100Yrs) |
5.186200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.299000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.215000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.407800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.094600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.853800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.113800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.560900E-04 |
| Classical-VS-Follicular |
4.693000E-01 |
| Classical-VS-Other |
1.268210E-01 |
| Classical-VS-Normal |
3.64640539984862E-11 |
| Tall-VS-Follicular |
2.663100E-03 |
| Tall-VS-Other |
8.180600E-01 |
| Tall-VS-Normal |
9.28879195782883E-12 |
| Follicular-VS-Other |
2.572400E-02 |
| Follicular-VS-Normal |
1.048590E-04 |
| Other-VS-Normal |
3.613100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.56390000949358E-09 |
| Normal-vs-N1 |
2.82509999838254E-08 |
| N0-vs-N1 |
3.326000E-01 |
|
|
